MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
issuance of common stock...
$5,712,700
Net proceeds from
exercise of warrants
$2,215,828
Net cash provided by
financing activities from...
$7,928,528
Net (decrease)
increase in cash, cash...
-$1,690,960
Canceled cashflow
$7,928,528
Prepaid expenses, other
current assets and...
-$417,738
Depreciation and
amortization
$255,601
Inventories
-$94,002
Stock-based compensation
$80,373
Deferred revenue
$43,500
Accounts receivable
-$33,782
Change in provision for
bad debts
$5,423
Loss on write-off of
property and equipment
$5,212
Cash provided by
investing activities
$21,000
Net cash used in
operating activities from...
-$9,141,688
Canceled cashflow
$935,631
Net cash used in
investing activities from...
-$313,121
Net cash used by
discontinued operations
-$164,679
Canceled cashflow
$21,000
Net loss from
continuing operations
-$9,585,822
Unrealized gain on change in
fair value of...
$318,840
Accounts payable and
accrued liabilities
-$172,657
Purchase of property and
equipment
$313,121
Cash used in
operating activities
-$185,679
Back
Back
Cash Flow
source: myfinsight.com
APPLIED DNA SCIENCES INC (APDN)
APPLIED DNA SCIENCES INC (APDN)